» Articles » PMID: 33139380

-Specific IgA Secretion in the Female Reproductive Tract Induced Via Per-Oral Immunization Confers Protection Against Primary Challenge

Overview
Journal Infect Immun
Date 2020 Nov 3
PMID 33139380
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

is an obligate intracellular pathogen that causes sexually transmitted disease. In women, chlamydial infections may cause pelvic inflammatory disease (PID), ectopic pregnancy, and infertility. The role of antibodies in protection against a primary infection is unclear and was a focus of this work. Using the mouse infection model, we show that intestinal mucosa is infected via intranasal (i.n.) or per-oral (p.o.) inoculation and that unlike the female reproductive tract (FRT) mucosa, it halts systemic dissemination. Moreover, p.o. immunization or infection with confers protection against per-vaginal (p.v.) challenge, resulting in significantly decreased bacterial burden in the FRT, accelerated clearance, and reduced hydrosalpinx pathology. In contrast, subcutaneous (s.c.) immunization conferred no protection against the p.v. challenge. Both p.o. and s.c. immunizations induced -specific serum IgA. However, IgA was found only in the vaginal washes and fecal extracts of p.o.-immunized animals. Following a p.v. challenge, unimmunized control and s.c.-s.c.-immunized animals developed -specific intestinal IgA yet failed to develop IgA in the FRT, indicating that IgA response in the FRT relies on the FRT to gastrointestinal tract (GIT) antigen transport. Vaginal secretions of p.o.-immunized animals neutralize , resulting in significantly lower burden in the FRT and transport to the GIT. We also show that infection of the GIT is not necessary for induction of protective immunity in the FRT, a finding that is important for the development of p.o. subunit vaccines to target and possibly other sexually transmitted pathogens.

Citing Articles

A VCG-Based Multiepitope Vaccine Incorporating the Cholera Toxin A1 Subunit (MECA) Confers Protective Immunity Against Transcervical Challenge.

Medhavi F, Tanner T, Richardson S, Lundy S, Omosun Y, Eko F Biomedicines. 2025; 13(2).

PMID: 40002702 PMC: 11852492. DOI: 10.3390/biomedicines13020288.


The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants.

Vasquez-Martinez N, Guillen D, Moreno-Mendieta S, Sanchez S, Rodriguez-Sanoja R Polymers (Basel). 2023; 15(7).

PMID: 37050229 PMC: 10097111. DOI: 10.3390/polym15071615.


Enhanced IgA coating of bacteria in women with Lactobacillus crispatus-dominated vaginal microbiota.

Breedveld A, Schuster H, van Houdt R, Painter R, Mebius R, van der Veer C Microbiome. 2022; 10(1):15.

PMID: 35074009 PMC: 8787895. DOI: 10.1186/s40168-021-01198-4.


Immunopathogenesis of genital Chlamydia infection: insights from mouse models.

Dockterman J, Coers J Pathog Dis. 2021; 79(4).

PMID: 33538819 PMC: 8189015. DOI: 10.1093/femspd/ftab012.

References
1.
Brunham R, Kuo C, Cles L, Holmes K . Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun. 1983; 39(3):1491-4. PMC: 348123. DOI: 10.1128/iai.39.3.1491-1494.1983. View

2.
de la Maza L, Pal S, Khamesipour A, Peterson E . Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun. 1994; 62(5):2094-7. PMC: 186471. DOI: 10.1128/iai.62.5.2094-2097.1994. View

3.
Darville T, Andrews Jr C, Laffoon K, Shymasani W, Kishen L, Rank R . Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun. 1997; 65(8):3065-73. PMC: 175432. DOI: 10.1128/iai.65.8.3065-3073.1997. View

4.
Ramsey K, Newhall 5th W, Rank R . Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect Immun. 1989; 57(8):2441-6. PMC: 313467. DOI: 10.1128/iai.57.8.2441-2446.1989. View

5.
OMeara C, Armitage C, Harvie M, Timms P, Lycke N, Beagley K . Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PLoS One. 2013; 8(4):e61962. PMC: 3628704. DOI: 10.1371/journal.pone.0061962. View